FIRST ANALYSIS OF HOVON-65/GMMG-HD4 RANDOMIZED PHASE III TRIAL COMPARING BORTEZOMIB, ADRIAMYCINE, DEXAMETHASONE (PAD) VS VAD AS INDUCTION TREATMENT PRIOR TO HIGH DOSE MELPHALAN (HDM) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)

Sonneveld, P; van der Holt, B; Schmidt-Wolf, IGH; Bertsch, U; El Jarari, L; Salwender, H; Zweegman, S; Vallenga, E; Schubert, J; Blau, IW; Jie, GSK; Beverloo, B; Jauch, A; Hose, D; Schaafsma, R; Kersten, MJ; Delforge, Michel; Raymakers, RA; De Weerdt, O; Van der Griend, R; Weijermans, PW; Martin, Harry; Van der Velde, H; Lokhorst, HM; Goldschmidt, H

Haematologica

FIRST ANALYSIS OF HOVON-65/GMMG-HD4 RANDOMIZED PHASE III TRIAL COMPARING BORTEZOMIB, ADRIAMYCINE, DEXAMETHASONE (PAD) VS VAD AS INDUCTION TREATMENT PRIOR TO HIGH DOSE MELPHALAN (HDM) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)

Author:

Sonneveld, P

van der Holt, B ; Schmidt-Wolf, IGH ; Bertsch, U ; El Jarari, L ; Salwender, H ; Zweegman, S ; Vallenga, E ; Schubert, J ; Blau, IW ; Jie, GSK ; Beverloo, B ; Jauch, A ; Hose, D ; Schaafsma, R ; Kersten, MJ ; Delforge, Michel ; Raymakers, RA ; De Weerdt, O ; Van der Griend, R ; Weijermans, PW ; Martin, Harry ; Van der Velde, H ; Lokhorst, HM ; Goldschmidt, H

Keywords:

1102 Cardiorespiratory Medicine and Haematology, Immunology

Haematologica FIRST ANALYSIS OF HOVON-65/GMMG-HD4 RANDOMIZED PHASE III TRIAL COMPARING BORTEZOMIB, ADRIAMYCINE, DEXAMETHASONE (PAD) VS VAD AS INDUCTION TREATMENT PRIOR TO HIGH DOSE MELPHALAN (HDM) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)

Author:

Keywords:

Haematologica

FIRST ANALYSIS OF HOVON-65/GMMG-HD4 RANDOMIZED PHASE III TRIAL COMPARING BORTEZOMIB, ADRIAMYCINE, DEXAMETHASONE (PAD) VS VAD AS INDUCTION TREATMENT PRIOR TO HIGH DOSE MELPHALAN (HDM) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)